Page last updated: 2024-09-05

sb 216763 and Pulmonary Arterial Remodeling

sb 216763 has been researched along with Pulmonary Arterial Remodeling in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cha, X; Chang, C; Han, S; Komal, S; Ouyang, X; Su, X; Wang, S; Xu, L; Yao, Y; Zang, M; Zhang, L	1

Other Studies

1 other study(ies) available for sb 216763 and Pulmonary Arterial Remodeling

Article	Year
Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction. Journal of molecular and cellular cardiology, 2020, Volume: 149 Topics: Animals; CARD Signaling Adaptor Proteins; Enzyme Activation; Fibroblasts; Glycogen Synthase Kinase 3 beta; Indoles; Inflammasomes; Inflammation; Male; Maleimides; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinase Inhibitors; Protein Multimerization; Rats, Sprague-Dawley; Vascular Remodeling	2020

Article

Year

Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction.

Journal of molecular and cellular cardiology, 2020, Volume: 149

Topics: Animals; CARD Signaling Adaptor Proteins; Enzyme Activation; Fibroblasts; Glycogen Synthase Kinase 3 beta; Indoles; Inflammasomes; Inflammation; Male; Maleimides; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinase Inhibitors; Protein Multimerization; Rats, Sprague-Dawley; Vascular Remodeling

2020